• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为佐剂靶点的炎性小体

Inflammasomes as Targets for Adjuvants.

作者信息

Ivanov Konstantin, Garanina Ekaterina, Rizvanov Albert, Khaiboullina Svetlana

机构信息

Kazan Federal University, 420008 Kazan, Russia.

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.

出版信息

Pathogens. 2020 Mar 30;9(4):252. doi: 10.3390/pathogens9040252.

DOI:10.3390/pathogens9040252
PMID:32235526
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7238254/
Abstract

Inflammasomes are an essential part of the innate immune system. They are necessary for the development of a healthy immune response against infectious diseases. Inflammasome activation leads to the secretion of pro-inflammatory cytokines such as IL-1β and IL-18, which stimulate the adaptive immune system. Inflammasomes activators can be used as adjuvants to provide and maintain the strength of the immune response. This review is focused on the mechanisms of action and the effects of adjuvants on inflammasomes. The therapeutic and prophylaxis significance of inflammasomes in infectious diseases is also discussed.

摘要

炎性小体是固有免疫系统的重要组成部分。它们对于针对传染病产生健康的免疫反应至关重要。炎性小体激活会导致促炎细胞因子如白细胞介素-1β和白细胞介素-18的分泌,从而刺激适应性免疫系统。炎性小体激活剂可作为佐剂来提供并维持免疫反应的强度。本综述聚焦于佐剂对炎性小体的作用机制及影响。还讨论了炎性小体在传染病中的治疗和预防意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf4a/7238254/3a1d9767d02a/pathogens-09-00252-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf4a/7238254/581eebefbc70/pathogens-09-00252-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf4a/7238254/f8081a349254/pathogens-09-00252-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf4a/7238254/3a1d9767d02a/pathogens-09-00252-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf4a/7238254/581eebefbc70/pathogens-09-00252-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf4a/7238254/f8081a349254/pathogens-09-00252-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf4a/7238254/3a1d9767d02a/pathogens-09-00252-g003.jpg

相似文献

1
Inflammasomes as Targets for Adjuvants.作为佐剂靶点的炎性小体
Pathogens. 2020 Mar 30;9(4):252. doi: 10.3390/pathogens9040252.
2
Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants.炎性小体介导的临床及实验性疫苗佐剂的免疫原性
Vaccines (Basel). 2020 Sep 22;8(3):554. doi: 10.3390/vaccines8030554.
3
Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation.炎症小体调控的研究进展:炎症小体激活的细胞、分子和发病机制调控。
Immunol Res. 2022 Oct;70(5):578-606. doi: 10.1007/s12026-022-09286-9. Epub 2022 May 24.
4
Inflammasomes and SARS-CoV-2 Infection.炎症小体与 SARS-CoV-2 感染
Viruses. 2021 Dec 14;13(12):2513. doi: 10.3390/v13122513.
5
Inflammasome-dependent and -independent IL-18 production mediates immunity to the ISCOMATRIX adjuvant.炎性体依赖和非依赖的 IL-18 产生介导了对 ISCOMATRIX 佐剂的免疫。
J Immunol. 2014 Apr 1;192(7):3259-68. doi: 10.4049/jimmunol.1302011. Epub 2014 Mar 7.
6
Inflammasomes as therapeutic targets in human diseases.炎症小体作为人类疾病的治疗靶点。
Signal Transduct Target Ther. 2021 Jul 2;6(1):247. doi: 10.1038/s41392-021-00650-z.
7
Inactivation of Inflammasomes by Pathogens Regulates Inflammation.病原体对炎性小体的失活作用调控炎症反应。
Biochemistry (Mosc). 2016 Nov;81(11):1326-1339. doi: 10.1134/S0006297916110109.
8
Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation.微藻三角褐指藻中的岩藻黄质通过调控 NF-κB 和 NLRP3 炎性小体的激活来抑制促炎细胞因子。
Sci Rep. 2021 Jan 12;11(1):543. doi: 10.1038/s41598-020-80748-6.
9
Aminated nanomicelles as a designer vaccine adjuvant to trigger inflammasomes and multiple arms of the innate immune response in lymph nodes.胺化纳米胶束作为一种定制疫苗佐剂,可触发炎性小体和淋巴结中固有免疫反应的多个分支。
Int J Nanomedicine. 2017 Oct 12;12:7501-7517. doi: 10.2147/IJN.S144623. eCollection 2017.
10
Innate and adaptive effects of inflammasomes on T cell responses.先天免疫和适应性免疫效应分子对 T 细胞应答的影响。
Curr Opin Immunol. 2013 Jun;25(3):359-65. doi: 10.1016/j.coi.2013.02.008. Epub 2013 Mar 7.

引用本文的文献

1
Basic Properties and Development Status of Aluminum Adjuvants Used for Vaccines.用于疫苗的铝佐剂的基本特性与发展现状
Vaccines (Basel). 2024 Oct 18;12(10):1187. doi: 10.3390/vaccines12101187.
2
Development of semisynthetic saponin immunostimulants.半合成皂苷免疫刺激剂的研发
Med Chem Res. 2024;33(8):1292-1306. doi: 10.1007/s00044-024-03227-x. Epub 2024 May 18.
3
U-shaped relationship found between fibrinogen-to-albumin ratio and systemic inflammation response index in osteoporotic fracture patients.研究发现,纤维蛋白原/白蛋白比值与骨质疏松性骨折患者的全身炎症反应指数呈 U 型关系。

本文引用的文献

1
Frequency and cost of live vaccines administered too soon after prior live vaccine in children aged 12 months through 6 years, 2014-2017.12 月龄至 6 岁儿童在接种前次活疫苗后过早接种活疫苗的频率和费用。2014-2017 年。
Vaccine. 2019 Oct 31;37(46):6868-6873. doi: 10.1016/j.vaccine.2019.09.058. Epub 2019 Sep 25.
2
Flagellin/NLRC4 Pathway Rescues NLRP3-Inflammasome Defect in Dendritic Cells From HIV-Infected Patients: Perspective for New Adjuvant in Immunocompromised Individuals.鞭毛蛋白/NLRC4 通路挽救 HIV 感染患者树突状细胞中 NLRP3 炎症小体缺陷:免疫功能低下个体新型佐剂的新视角。
Front Immunol. 2019 Jun 11;10:1291. doi: 10.3389/fimmu.2019.01291. eCollection 2019.
3
Sci Rep. 2024 May 17;14(1):11299. doi: 10.1038/s41598-024-61965-9.
4
Herpes Simplex Virus ICP27 Protein Inhibits AIM 2-Dependent Inflammasome Influencing Pro-Inflammatory Cytokines Release in Human Pigment Epithelial Cells (hTert-RPE 1).单纯疱疹病毒 ICP27 蛋白抑制 AIM2 依赖性炎性体影响人视网膜色素上皮细胞(hTert-RPE1)中促炎细胞因子的释放。
Int J Mol Sci. 2024 Apr 23;25(9):4608. doi: 10.3390/ijms25094608.
5
Progress towards Adjuvant Development: Focus on Antiviral Therapy.辅助药物研发进展:聚焦抗病毒治疗。
Int J Mol Sci. 2023 May 25;24(11):9225. doi: 10.3390/ijms24119225.
6
The Autoinducer N-Octanoyl-L-Homoserine Lactone (C8-HSL) as a Potential Adjuvant in Vaccine Formulations.自诱导剂N-辛酰基-L-高丝氨酸内酯(C8-HSL)作为疫苗制剂中的潜在佐剂
Pharmaceuticals (Basel). 2023 May 8;16(5):713. doi: 10.3390/ph16050713.
7
A flagellin-conjugate protein induces dual NLRC4- and NLRP3-inflammasome activation which modulates inflammatory cytokine secretion from macrophages.鞭毛蛋白偶联蛋白诱导 NLRC4 和 NLRP3 炎性小体的双重激活,从而调节巨噬细胞中炎症细胞因子的分泌。
Front Immunol. 2023 Mar 21;14:1136669. doi: 10.3389/fimmu.2023.1136669. eCollection 2023.
8
Biomarkers and Pathogenesis of Infectious and Autoimmune Diseases.感染性疾病和自身免疫性疾病的生物标志物与发病机制
Pathogens. 2022 Dec 22;12(1):14. doi: 10.3390/pathogens12010014.
9
Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populations.纳米材料在健康和疾病中的免疫毒性:鉴定易感人群中免疫调节剂的当前挑战和新兴方法。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Nov;14(6):e1804. doi: 10.1002/wnan.1804.
10
Glaucoma Cases Following SARS-CoV-2 Vaccination: A VAERS Database Analysis.接种 SARS-CoV-2 疫苗后出现青光眼病例:疫苗不良事件报告系统(VAERS)数据库分析
Vaccines (Basel). 2022 Sep 28;10(10):1630. doi: 10.3390/vaccines10101630.
Exotoxin A-PLGA nanoconjugate vaccine against Pseudomonas aeruginosa infection: protectivity in murine model.
外毒素 A-PLGA 纳米缀合物疫苗防治铜绿假单胞菌感染:在小鼠模型中的保护作用。
World J Microbiol Biotechnol. 2019 Jun 11;35(6):94. doi: 10.1007/s11274-019-2669-y.
4
Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review.免疫佐剂 QS-21 的作用机制和临床特征的最新认识:综述。
Phytomedicine. 2019 Jul;60:152905. doi: 10.1016/j.phymed.2019.152905. Epub 2019 Mar 30.
5
Proteomic analysis of cholera toxin adjuvant-stimulated human monocytes identifies Thrombospondin-1 and Integrin-β1 as strongly upregulated molecules involved in adjuvant activity.霍乱毒素佐剂刺激的人单核细胞的蛋白质组学分析鉴定出血小板反应蛋白-1 和整合素-β1 作为强烈上调的参与佐剂活性的分子。
Sci Rep. 2019 Feb 26;9(1):2812. doi: 10.1038/s41598-019-38726-0.
6
RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial.基于 RNA 的佐剂 CV8102 在首次人体试验中增强了一种已许可狂犬病疫苗的免疫原性。
Vaccine. 2019 Mar 22;37(13):1819-1826. doi: 10.1016/j.vaccine.2019.02.024. Epub 2019 Feb 21.
7
Cholera toxin B induces interleukin-1β production from resident peritoneal macrophages through the pyrin inflammasome as well as the NLRP3 inflammasome.霍乱毒素 B 通过 pyrin 炎性小体和 NLRP3 炎性小体诱导驻留腹腔巨噬细胞产生白细胞介素-1β。
Int Immunol. 2019 Sep 18;31(10):657-668. doi: 10.1093/intimm/dxz004.
8
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want.优化疫苗中铝佐剂的利用:你可能会得偿所愿。
NPJ Vaccines. 2018 Oct 10;3:51. doi: 10.1038/s41541-018-0089-x. eCollection 2018.
9
Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.口服幽门螺杆菌全细胞灭活疫苗和多种突变霍乱毒素的临床前免疫原性和保护效力:一种新型无毒黏膜佐剂。
Vaccine. 2018 Oct 1;36(41):6223-6230. doi: 10.1016/j.vaccine.2018.07.073. Epub 2018 Aug 14.
10
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines.佐剂的相关性:已上市疫苗中的佐剂概述。
Semin Immunol. 2018 Oct;39:14-21. doi: 10.1016/j.smim.2018.05.001. Epub 2018 May 23.